本页面由Tiger Trade Technology Pte. Ltd.提供服务

10x Genomics, Inc.

68.59
+2.213.33%
盘后69.140.5500+0.80%19:59 EDT
成交量:182.97万
成交额:1.26亿
市值:89.37亿
市盈率:-116.58
高:69.67
开:67.40
低:67.00
收:66.38
52周最高:69.67
52周最低:11.16
股本:1.30亿
流通股本:1.18亿
量比:0.75
换手率:1.55%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
净资产收益率:-9.40%
总资产收益率:-5.05%
市净率:10.83
市盈率(LYR):-196.50

数据加载中...

2021/03/01

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/10/05

重要事件披露

8-K - Current report
2020/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/08

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report